Wambeke David J. insider trades
Wambeke David J. has filed 7 Form 4s with the SEC that we hold, for DiaMedica Therapeutics Inc. (DMAC) (Chief Business Officer) and NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) (Chief Business Officer). Across all of them we count 5 purchases worth $1.7M and 0 sales worth $0 reported on Form 4. In the last 12 months: 2 purchases ($737.0K) and 0 sales ($0). The largest single trade was a purchase of 468,750 shares of DiaMedica Therapeutics Inc. worth $750.0K, dated 2023-04-10. The first filing on our record is dated 2023-04-11 and the latest 2026-09-08.
DiaMedica Therapeutics Inc. (DMAC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-04-10 | P, purchase reported on Form 4 | 468,750 | $750.0K | 2023-04-11 |
| 2023-06-23 | P, purchase reported on Form 4 | 38,364 | $150.0K | 2023-06-26 |
| 2023-11-16 | P, purchase reported on Form 4 | 20,000 | $49.2K | 2023-11-16 |
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-01 | P, purchase reported on Form 4 | 1,000,000 | $670.0K | 2026-03-03 |
| 2026-08-27 | P, purchase reported on Form 4 | 33,333 | $67.0K | 2026-09-08 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1971798) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms